August 11, 2025
2 min watch
Key takeaways:
- A traits survey highlights worldwide retina practices.
- Monitoring of inactive age-related macular degeneration ranges between each 6 months and each 12 months.
LONG BEACH, Calif. — On the American Society of Retina Specialists annual assembly, Sunir J. Garg, MD, FACS, FASRS, overviewed key findings from the International Traits in Retina Survey.
In keeping with Garg, it’s common follow within the U.S. and another areas to see sufferers with inactive age-related macular degeneration as soon as each 12 months for monitoring. Nonetheless, specialists in some international locations will see these sufferers each 6 months.
Moreover, therapy traits for sufferers with recalcitrant diabetic macular edema various between the U.S. and Europe.
“Within the U.S., there’s a sturdy desire to switching to a special anti-VEGF, and we noticed that in several localities,” Garg instructed Healio. “However in sure components of the world, particularly Europe, there was a bent to have your second agent be a steroid injection.”
There have been reported variations within the peeling strategies used to deal with sufferers with grade C proliferative vitreoretinopathy.
“Within the U.S., there’s a desire to peel simply the star fold alone,” Garg mentioned. “However in different places on this planet, there’s a tendency to additionally peel the [internal limiting membrane] over the macula. We’ve seen some information to assist that.”
As well as, a lot of specialists around the globe, together with the U.S., reported that after performing a routine vitrectomy for macular pathology, they both go away the attention fluid stuffed or carry out a partial air fill, in line with Garg.
“It was fascinating that I used to be within the minority, leaving my sufferers the whole air/gasoline fill,” he mentioned.
Sources/Disclosures
Collapse
Garg SJ. International traits. Offered at: American Society of Retina Specialists annual assembly; July 30-Aug. 2, 2025; Lengthy Seaside, California.
Disclosures:
Garg stories no related monetary disclosures.
